Scientists report that they have developed a novel compound that appears to protect mice against developing movement problems associated with Parkinson’s disease (PD).
The research, which could one day in the future translate into a therapy that could halt the progression of PD and thereby prevent the symptoms of the disease, appears in ACS’ Journal of Medicinal Chemistry.
Onyou Hwang, Ki Duk Park and colleagues explain that PD, which affects an estimated 4 million to 10 million people worldwide, is a progressive movement disorder with no known cure. It often starts with slight tremors and gets worse over time. Muscles go stiff. Walking becomes difficult. Speech is slurred. No one knows for certain what causes the disease, but research has shown that it’s linked with the loss of nerve cells in the brain that secrete dopamine, a chemical that is involved in movement and emotion. To find a potential new therapy for PD, the research team searched for a way to shield these brain cells.
They made 56 compounds and tested them to see which ones boosted the production of proteins that protect dopamine-releasing neurons from damage. Of those, one, which they call “12g,” proved to be the most active. Interestingly, it protected mice from developing PD-like symptoms in one laboratory test. “Taken together, 12g was found to effectively prevent the motor deficits that are associated with PD,” they say.
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- NHS urged to recognise 'Covid tongue' as sign of the disease as experts fear a fifth of cases are being missed because unusual symptoms are left off official liston January 22, 2021 at 7:12 am
Professor Tim Spector, from King's College London, said he's seeing an increasing number of infected patients with sores on their tongue and unusual mouth ulcers.
- The Physician Who Presaged the Germ Theory of Disease Nearly 500 Years Agoon January 22, 2021 at 4:28 am
As a physician in Verona, Girolamo Fracastoro observed the mortifying effects of the disease firsthand. More virulent and contagious than syphilis today, the disease would be responsible for an ...
- Global Parkinson's Disease (PD) Drugs Market Research During 2020-2024 | Industry Impact Analysis Due to COVID-19 Spread | Technavioon January 21, 2021 at 11:38 pm
The Parkinson's disease (PD) drugs market is poised to grow by USD 1.57 billion during 2020-2024 progressing at a CAGR of almost 6% during the forecast period. Worried about the impact of COVID-19 on ...
- Study examines association between gut mycobiome and Parkinson’s diseaseon January 21, 2021 at 10:11 am
The bacterial gut microbiome is strongly associated with Parkinson's disease (PD), but no studies had previously investigated he role of fungi in the gut.
- Study suggests that gut fungi are not associated with Parkinson's diseaseon January 21, 2021 at 9:46 am
The bacterial gut microbiome is strongly associated with Parkinson's disease (PD), but no studies had previously investigated he role of fungi in the gut. In this novel study published in the Journal ...
- Scientists may have found a way to 'de-age the brain': Switching off certain immune cells could delay the onset of Alzheimer's disease, cancer and heart disease, study findson January 20, 2021 at 8:37 am
In the study, researchers from Stanford Medicine switched off myeloid cells in old mice, as well as myeloid cells in culture from people older than 65 and under 35.
- New Parkinson's disease therapeutics discoveredon January 20, 2021 at 4:38 am
Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson's disease. The findings were ...
- Eye tests can predict cognitive decline in Parkinson’s disease 18 months aheadon January 20, 2021 at 3:20 am
In a new study, researchers found that simple vision tests can predict which people with Parkinson’s disease will develop cognitive impairment and possible dementia 18 months later. The study adds to ...
- BMP5/7 protein offers promising therapeutics that could halt the progression of Parkinson's diseaseon January 19, 2021 at 10:39 pm
Gurion University of the Negev researchers have discovered that the protein BMP5/7 offers promising therapeutics that could slow down or halt the progression of Parkinson's disease.
- How Exercise Helps Prevent and Treat Parkinson’s Diseaseon January 19, 2021 at 10:34 pm
Parkinson's disease had caused 61-year-old John Cullen to slouch and drag his foot while walking. Then Cullen started powerlifting. He's since become strong enough to dead lift 465 pounds. Beyond ...
via Bing News